Showing results (241-250 of 382) with videos related to
Sort By:
Pageof 39
Prostate Cancer and Prostatic Diseases|October 16, 2019
A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancerAshley E Ross, Paula J Hurley, Phuoc T Tran, et al.Bladder Cancer (Amsterdam, Netherlands)|August 22, 2017
High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder CancerMax Kates, Meera R Chappidi, Aaron Brant, et al.Urologic Oncology|March 28, 2015
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomesNilay M Gandhi, Alexander Baras, Enrico Munari, et al.Journal for Immunotherapy of Cancer|September 1, 2023
KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy responseCasey R Ager, Mingxuan Zhang, Matthew Chaimowitz, et al.Biorxiv : the Preprint Server for Biology|January 3, 2024
Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonistPeter K Um, Monali Praharaj, Kara A Lombardo, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2003
CD4+ T cells pass through an effector phase during the process of in vivo tolerance inductionChing-Tai Huang, David L Huso, Zhenbing Lu, et al.The Journal of Urology|November 25, 2015
A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder CancerJong Chul Park, Nilay M Gandhi, Michael A Carducci, et al.The Prostate|June 19, 2008
Radiotherapy augments the immune response to prostate cancer in a time-dependent mannerTimothy J Harris, Edward L Hipkiss, Scott Borzillary, et al.Oncotarget|October 27, 2017
Racial differences in prostate inflammation: results from the REDUCE studyAdriana C Vidal, Zinan Chen, Lauren E Howard, et al.The Prostate|March 10, 2009
Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE IIMing-Hsi Wang, Kathy J Helzlsouer, Michael W Smith, et al.Pageof 39